Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / SHS USD
-
Number of holders
-
458
-
Total 13F shares, excl. options
-
55.6M
-
Shares change
-
-625K
-
Total reported value, excl. options
-
$6.9B
-
Value change
-
-$97.9M
-
Put/Call ratio
-
1.4
-
Number of buys
-
200
-
Number of sells
-
-211
-
Price
-
$123.97
Significant Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q2 2023
527 filings reported holding JAZZ - Jazz Pharmaceuticals plc - SHS USD as of Q2 2023.
Jazz Pharmaceuticals plc - SHS USD (JAZZ) has 458 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 55.6M shares
.
Largest 10 shareholders include BlackRock Inc. (6.88M shares), VANGUARD GROUP INC (6.35M shares), STATE STREET CORP (2.37M shares), LSV ASSET MANAGEMENT (2.32M shares), WELLINGTON MANAGEMENT GROUP LLP (1.87M shares), JPMORGAN CHASE & CO (1.7M shares), SAMLYN CAPITAL, LLC (1.35M shares), Polaris Capital Management, LLC (1.3M shares), RENAISSANCE TECHNOLOGIES LLC (1.29M shares), and Deep Track Capital, LP (1.25M shares).
This table shows the top 458 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.